175 related articles for article (PubMed ID: 35642343)
1. The Prognostic Impact of Tumor Border Configuration, Tumor Budding and Tumor Stroma Ratio in Colorectal Carcinoma.
Aboelnasr LS; El-Rebey HS; Mohamed A; Abdou AG
Turk Patoloji Derg; 2023; 39(1):83-93. PubMed ID: 35642343
[TBL] [Abstract][Full Text] [Related]
2. The relationship of tumor budding with GOLPH3 expression and histopathological prognostic parameters in colorectal adenocarcinoma.
Komut N; Bektas S; Yildirim E
Ann Diagn Pathol; 2022 Jun; 58():151933. PubMed ID: 35364414
[TBL] [Abstract][Full Text] [Related]
3. Exploring the combination of tumor-stroma ratio, tumor-infiltrating lymphocytes, and tumor budding with WHO histopathological grading on early-stage oral squamous cell carcinoma prognosis.
Silva GVD; da Silva Dolens E; Paranaíba LMR; Ayroza ALC; Gurgel Rocha CA; Almangush A; Salo T; Brennan PA; Coletta RD
J Oral Pathol Med; 2023 May; 52(5):402-409. PubMed ID: 36149755
[TBL] [Abstract][Full Text] [Related]
4. Tumor Budding in Colorectal Carcinoma Showing a Paradoxical Mitotic Index (Via PHH3) With Possible Association to the Tumor Stromal Microenvironment.
Hacking S; Sajjan S; Angert M; Ebare K; Jin C; Chavarria H; Kataria N; Zhang L; Cho M; Thomas R; Lee L; Nasim M
Appl Immunohistochem Mol Morphol; 2020 Sep; 28(8):627-634. PubMed ID: 31567276
[TBL] [Abstract][Full Text] [Related]
5. Intra-tumoral budding in preoperative biopsy specimens predicts lymph node and distant metastasis in patients with colorectal cancer.
Giger OT; Comtesse SC; Lugli A; Zlobec I; Kurrer MO
Mod Pathol; 2012 Jul; 25(7):1048-53. PubMed ID: 22481282
[TBL] [Abstract][Full Text] [Related]
6. Proposal for a 10-high-power-fields scoring method for the assessment of tumor budding in colorectal cancer.
Karamitopoulou E; Zlobec I; Kölzer V; Kondi-Pafiti A; Patsouris ES; Gennatas K; Lugli A
Mod Pathol; 2013 Feb; 26(2):295-301. PubMed ID: 23018875
[TBL] [Abstract][Full Text] [Related]
7. Tumor Budding and PDC Grade Are Stage Independent Predictors of Clinical Outcome in Mismatch Repair Deficient Colorectal Cancer.
Ryan É; Khaw YL; Creavin B; Geraghty R; Ryan EJ; Gibbons D; Hanly A; Martin ST; O'Connell PR; Winter DC; Sheahan K
Am J Surg Pathol; 2018 Jan; 42(1):60-68. PubMed ID: 29112018
[TBL] [Abstract][Full Text] [Related]
8. Tumor budding is an independent predictor of outcome in AJCC/UICC stage II colorectal cancer.
Betge J; Kornprat P; Pollheimer MJ; Lindtner RA; Schlemmer A; Rehak P; Vieth M; Langner C
Ann Surg Oncol; 2012 Nov; 19(12):3706-12. PubMed ID: 22669453
[TBL] [Abstract][Full Text] [Related]
9. Budding as a risk factor for lymph node metastasis in pT1 or pT2 well-differentiated colorectal adenocarcinoma.
Okuyama T; Oya M; Ishikawa H
Dis Colon Rectum; 2002 May; 45(5):628-34. PubMed ID: 12004212
[TBL] [Abstract][Full Text] [Related]
10. Colorectal Carcinomas: Searching for New Histological Parameters Associated with Lymph Node Metastases.
Jurescu A; Văduva A; Vița O; Gheju A; Cornea R; Lăzureanu C; Mureșan A; Cornianu M; Tăban S; Dema A
Medicina (Kaunas); 2023 Oct; 59(10):. PubMed ID: 37893479
[No Abstract] [Full Text] [Related]
11. Tumor budding in colorectal carcinomas.
Sert Bektaş S; Inan Mamak G; Cırış IM; Bozkurt KK; Kapucuoğlu N
Turk Patoloji Derg; 2012; 28(1):61-6. PubMed ID: 22207434
[TBL] [Abstract][Full Text] [Related]
12. High-grade intratumoral tumor budding is a predictor for lymphovascular invasion and adverse outcome in stage II colorectal cancer.
Marx AH; Mickler C; Sauter G; Simon R; Terracciano LM; Izbicki JR; Clauditz TS
Int J Colorectal Dis; 2020 Feb; 35(2):259-268. PubMed ID: 31838579
[TBL] [Abstract][Full Text] [Related]
13. Intratumoral budding as a potential parameter of tumor progression in mismatch repair-proficient and mismatch repair-deficient colorectal cancer patients.
Lugli A; Vlajnic T; Giger O; Karamitopoulou E; Patsouris ES; Peros G; Terracciano LM; Zlobec I
Hum Pathol; 2011 Dec; 42(12):1833-40. PubMed ID: 21664647
[TBL] [Abstract][Full Text] [Related]
14. A three-tier classification system based on the depth of submucosal invasion and budding/sprouting can improve the treatment strategy for T1 colorectal cancer: a retrospective multicenter study.
Kawachi H; Eishi Y; Ueno H; Nemoto T; Fujimori T; Iwashita A; Ajioka Y; Ochiai A; Ishiguro S; Shimoda T; Mochizuki H; Kato Y; Watanabe H; Koike M; Sugihara K
Mod Pathol; 2015 Jun; 28(6):872-9. PubMed ID: 25720321
[TBL] [Abstract][Full Text] [Related]
15. The role of tumor budding in colorectal adenocarcinoma: Possible involvement of the intestinal cancer stem cell marker Lgr5.
Sadek SA; A Rehim DM; Fatima S
Indian J Pathol Microbiol; 2020; 63(1):32-37. PubMed ID: 32031119
[TBL] [Abstract][Full Text] [Related]
16. Tumor budding in colorectal carcinoma: An institutional interobserver reliability and prognostic study of colorectal adenocarcinoma cases.
Hacking S; Angert M; Jin C; Kline M; Gupta N; Cho M; Thomas R; Lee L; Chavarria H; Nasim M
Ann Diagn Pathol; 2019 Dec; 43():151420. PubMed ID: 31731034
[TBL] [Abstract][Full Text] [Related]
17. Tumor budding is a strong and reproducible prognostic marker in T3N0 colorectal cancer.
Wang LM; Kevans D; Mulcahy H; O'Sullivan J; Fennelly D; Hyland J; O'Donoghue D; Sheahan K
Am J Surg Pathol; 2009 Jan; 33(1):134-41. PubMed ID: 18971777
[TBL] [Abstract][Full Text] [Related]
18. Tumor budding to investigate local invasion, metastasis and prognosis in temporal bone squamous cell carcinoma.
Alessandrini L; Zanoletti E; Cazzador D; Sbaraglia M; Franz L; Tealdo G; Frigo AC; Blandamura S; Nicolai P; Mazzoni A; Marioni G
Pathol Res Pract; 2022 Jan; 229():153719. PubMed ID: 34953406
[TBL] [Abstract][Full Text] [Related]
19. Invasive front of colorectal cancer: dynamic interface of pro-/anti-tumor factors.
Zlobec I; Lugli A
World J Gastroenterol; 2009 Dec; 15(47):5898-906. PubMed ID: 20014453
[TBL] [Abstract][Full Text] [Related]
20. The prognostic role of tumor budding and tumor-stroma ratio in pulmonary metastasis of colorectal carcinoma.
Karjula T; Kemi N; Niskakangas A; Mustonen O; Puro I; Pohjanen VM; Kuopio T; Elomaa H; Ahtiainen M; Mecklin JP; Seppälä TT; Wirta EV; Sihvo E; Väyrynen JP; Yannopoulos F; Helminen O
Eur J Surg Oncol; 2023 Jul; 49(7):1298-1306. PubMed ID: 36841693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
